{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:45:03Z","timestamp":1791279903887,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology, Japan","doi-asserted-by":"crossref","award":["19591182"],"award-info":[{"award-number":["19591182"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.cyto.2012.01.019","type":"journal-article","created":{"date-parts":[[2012,2,26]],"date-time":"2012-02-26T00:15:43Z","timestamp":1330215343000},"page":"267-273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Up-regulation of IL-33 expression in various types of murine cells by IL-3 and IL-4"],"prefix":"10.1016","volume":"58","author":[{"given":"Wei-Hua","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Qing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2012.01.019_b0005","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0002-9440(10)63631-0","article-title":"Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules","volume":"163","author":"Baekkevold","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cyto.2012.01.019_b0010","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1073\/pnas.0606854104","article-title":"IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo","volume":"104","author":"Carriere","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cyto.2012.01.019_b0015","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2012.01.019_b0020","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/intimm\/dxn060","article-title":"IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells","volume":"20","author":"Smithgall","year":"2008","journal-title":"Int Immunol"},{"key":"10.1016\/j.cyto.2012.01.019_b0025","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nrd2660","article-title":"The IL-33\/ST2 pathway: therapeutic target and novel biomarker","volume":"7","author":"Kakkar","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.cyto.2012.01.019_b0030","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nri2735","article-title":"How are TH2-type immune responses initiated and amplified?","volume":"10","author":"Paul","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cyto.2012.01.019_b0035","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.4049\/jimmunol.179.4.2051","article-title":"Cutting edge: the ST2 ligand IL-33 potently activates and drives maturation of human mast cells","volume":"179","author":"Allakhverdi","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2012.01.019_b0040","doi-asserted-by":"crossref","first-page":"10913","DOI":"10.1073\/pnas.0801898105","article-title":"IL-33 exacerbates antigen-induced arthritis by activating mast cells","volume":"105","author":"Xu","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cyto.2012.01.019_b0045","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.4049\/jimmunol.181.9.5981","article-title":"An IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor","volume":"181","author":"Suzukawa","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2012.01.019_b0050","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1182\/blood-2008-05-157818","article-title":"Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33","volume":"113","author":"Pecaric-Petkovic","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2012.01.019_b0055","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.jaci.2008.04.005","article-title":"A novel IL-1 family cytokine, IL-33, potently activates human eosinophils","volume":"121","author":"Cherry","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.cyto.2012.01.019_b0060","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/eji.200838575","article-title":"The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-\u03b3 production","volume":"39","author":"Bourgeois","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cyto.2012.01.019_b0065","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jaci.2009.02.026","article-title":"IL-33-activated dendritic cells induce an atypical TH2-type response","volume":"123","author":"Rank","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.cyto.2012.01.019_b0070","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nri2692","article-title":"Disease-associated functions of IL-33: the new kid in the IL-1 family","volume":"10","author":"Liew","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cyto.2012.01.019_b0075","doi-asserted-by":"crossref","first-page":"9773","DOI":"10.1073\/pnas.0901206106","article-title":"The cytokine interleukin-33 mediates anaphylactic shock","volume":"106","author":"Pushparaj","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cyto.2012.01.019_b0080","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.4049\/jimmunol.0802387","article-title":"Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells","volume":"183","author":"Pr\u00e9fontaine","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2012.01.019_b0085","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jaci.2009.12.935","article-title":"Increased IL-33 expression by epithelial cells in bronchial asthma","volume":"125","author":"Pr\u00e9fontaine","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.cyto.2012.01.019_b0090","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1365-2222.2009.03384.x","article-title":"IL-33: a tissue derived cytokine pathway involved in allergic inflammation and asthma","volume":"40","author":"Smith","year":"2010","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.cyto.2012.01.019_b0095","doi-asserted-by":"crossref","first-page":"26369","DOI":"10.1074\/jbc.M704916200","article-title":"Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation","volume":"282","author":"Hayakawa","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cyto.2012.01.019_b0100","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/intimm\/dxn037","article-title":"Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system","volume":"20","author":"Kondo","year":"2008","journal-title":"Int Immunol"},{"key":"10.1016\/j.cyto.2012.01.019_b0105","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3899\/jrheum.090492","article-title":"Increased levels of interleukin 33 in sera and synovial fluid from patients with active rheumatoid arthritis","volume":"37","author":"Matsuyama","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cyto.2012.01.019_b0110","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00535-010-0245-1","article-title":"Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis","volume":"45","author":"Kobori","year":"2010","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.cyto.2012.01.019_b0115","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1136\/ard.2009.119321","article-title":"The IL-1-like cytokine IL-33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis","volume":"69","author":"Manetti","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cyto.2012.01.019_b0120","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.4049\/jimmunol.0903306","article-title":"IL-33 induces IL-13-dependent cutaneous fibrosis","volume":"184","author":"Rankin","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2012.01.019_b0125","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1084\/jem.20071868","article-title":"IL-33 reduces the development of atherosclerosis","volume":"205","author":"Miller","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2012.01.019_b0130","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/nm.2156","article-title":"Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection","volume":"16","author":"Alves-Filho","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.cyto.2012.01.019_b0135","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.immuni.2009.05.007","article-title":"Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases","volume":"31","author":"L\u00fcthi","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2012.01.019_b0140","doi-asserted-by":"crossref","first-page":"7890","DOI":"10.4049\/jimmunol.0802449","article-title":"Caspase-1, caspase-8, and calpain are dispensable for IL-33 release by macrophages","volume":"183","author":"Ohno","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2012.01.019_b0145","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1365-2567.2009.03221.x","article-title":"Expression and regulation of interleukin-33 in human monocytes","volume":"130","author":"Nile","year":"2010","journal-title":"Immunology"},{"key":"10.1016\/j.cyto.2012.01.019_b0150","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1189\/jlb.1207830","article-title":"Induction of IL-33 expression and activity in central nervous system glia","volume":"84","author":"Hudson","year":"2008","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.cyto.2012.01.019_b0155","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1172\/JCI30634","article-title":"IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system","volume":"117","author":"Sanada","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cyto.2012.01.019_b0160","doi-asserted-by":"crossref","first-page":"9021","DOI":"10.1073\/pnas.0812690106","article-title":"The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1","volume":"106","author":"Cayrol","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cyto.2012.01.019_b0165","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.4049\/jimmunol.1003020","article-title":"The danger signal, extracellular ATP, is a sensor for an airborne allergen and triggers IL-33 release and innate Th2-yype responses","volume":"186","author":"Kouzaki","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2012.01.019_b0170","doi-asserted-by":"crossref","first-page":"e11944","DOI":"10.1371\/journal.pone.0011944","article-title":"IL-33 is produced by mast cells and regulates IgE-dependent inflammation","volume":"5","author":"Hsu","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2012.01.019_b0175","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbrc.2009.04.081","article-title":"IL-33, a recently identified interleukin-1 gene family member, is expressed in human adipocytes","volume":"384","author":"Wood","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cyto.2012.01.019_b0180","first-page":"1845","article-title":"Endogenous interleukin 1\u03b1 must be transported to the nucleus to exert its activity in human endothelial cells","volume":"14","author":"Maier","year":"1994","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cyto.2012.01.019_b0185","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1016\/S0021-9258(18)61450-4","article-title":"The interleukin-1 receptor binds the human interleukin-1\u03b1 precursor but not the interleukin-1\u03b2 precursor","volume":"262","author":"Mosley","year":"1987","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cyto.2012.01.019_b0190","doi-asserted-by":"crossref","first-page":"8194","DOI":"10.4049\/jimmunol.181.12.8194","article-title":"Cutting edge: critical role for mesothelial cells in necrosis-induced inflammation through the recognition of IL-1\u03b1 released from dying cells","volume":"181","author":"Eigenbrod","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2012.01.019_b0195","doi-asserted-by":"crossref","first-page":"19420","DOI":"10.1074\/jbc.M901744200","article-title":"Interleukin-33 is biologically active independently of caspase-1 cleavage","volume":"284","author":"Talabot-Ayer","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cyto.2012.01.019_b0200","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/cmi.2010.3","article-title":"The enigmatic processing and secretion of interleukin-33","volume":"7","author":"Zhao","year":"2010","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.cyto.2012.01.019_b0205","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1111\/j.1365-2222.2008.03114.x","article-title":"Association of serum interleukin-33 level and the interleukin-33 genetic variant with Japanese cedar pollinosis","volume":"38","author":"Sakashita","year":"2008","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.cyto.2012.01.019_b0210","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/eji.200526275","article-title":"Interleukin 4-triggered, STAT6-dependent production of a factor that induces mouse mast cell apoptosis","volume":"36","author":"Hu","year":"2006","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cyto.2012.01.019_b0215","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.4049\/jimmunol.155.4.2134","article-title":"An essential role of prostaglandin E on mouse mast cell induction","volume":"155","author":"Hu","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2012.01.019_b0220","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1182\/blood.V89.2.526","article-title":"Tumor necrosis factor-\u03b1- and interleukin-6-triggered mast cell development from mouse spleen cells","volume":"89","author":"Hu","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2012.01.019_b0225","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0165-2478(94)90054-X","article-title":"Up-regulation of cytokine production in alveolar macrophages by histogranin, a novel endogenous pentadecapeptide","volume":"41","author":"Lemaire","year":"1994","journal-title":"Immunol Lett"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466612000518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466612000518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:49:00Z","timestamp":1760906940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466612000518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S1043466612000518"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2012.01.019","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Up-regulation of IL-33 expression in various types of murine cells by IL-3 and IL-4","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2012.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}